drugset / Trial / NCT00134810

Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome

NCT00134810 ↗

Phase 2 Completed 381 enrolled Ipsen
RandomizedParallel-groupDouble-blindTreatment

Summary

The main purpose of this study is to determine which is the best dose of a drug known as Dysport to give when treating one's type of upper back pain. The study will also examine the side effects of this treatment and its overall effect on one's disorder.

Timeline

Start
2005-03
Primary completion
2006-05-18
Completion
2006-05-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic — —